← back to search

Roger Trinh

AbbVie (United States) · US
Area of research
Hepatology · Infectious Diseases
Research interest
Research interests include Hepatitis C virus research, HIV/AIDS drug development and treatment, Systemic Lupus Erythematosus Research, and Liver Disease Diagnosis and Treatment.
h-index
18
citations
2,891
works
63
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial
Journal of Hepatology 2019cited by 152position: middledoi
Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
New England Journal of Medicine 2018cited by 432position: middledoi
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
Hepatology 2018cited by 180position: middledoi
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study
Clinical Infectious Diseases 2018cited by 146position: middledoi
Glecaprevir/Pibrentasvir in patients with chronic <scp>HCV</scp> genotype 3 infection: An integrated phase 2/3 analysis
Journal of Viral Hepatitis 2018cited by 41position: middledoi
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir
The Journal of Infectious Diseases 2017cited by 22position: middledoi
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
JAMA 2015cited by 305position: middledoi
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
New England Journal of Medicine 2014cited by 876position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David Wyles · Denver Health Medical Center4 papers (2015–2018)Peter Ruane · Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics4 papers (2015–2018)Yiran Hu · Wenzhou Medical University3 papers (2015–2018)Kosh Agarwal · King's College Hospital NHS Foundation Trust3 papers (2014–2018)Nancy S. Shulman · AbbVie (United States)3 papers (2017–2018)Sandra Lovell · AbbVie (United States)3 papers (2014–2019)Paul Y. Kwo · Palo Alto University2 papers (2018–2018)Gretja Schnell · AbbVie (United States)2 papers (2015–2019)Preethi Krishnan · AbbVie (United States)2 papers (2018–2018)Xavier Forns · Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer2 papers (2014–2018)Andrew Campbell · AbbVie (United States)2 papers (2014–2015)Mark Sulkowski · Johns Hopkins Bayview Medical Center2 papers (2015–2018)Jürgen K. Rockstroh · University of Padua2 papers (2018–2018)Federico Mensa · BioNTech (Germany)2 papers (2018–2019)— · 2 papers (2015–2017)Jihad Slim · The University of Texas Health Science Center at Houston2 papers (2015–2018)Rolando M. Viani · AstraZeneca (United States)2 papers (2017–2018)Abhishek Gulati · Indiana University School of Medicine2 papers (2018–2018)David Mutimer · University of Birmingham2 papers (2018–2018)Teresa I. Ng · AbbVie (United States)2 papers (2018–2018)